They considered it reasonable to use S3M test values between 7% and 14% for the cut-off point for biopsy decisions, where cut-off values below 10% would increase sensitivity for Gleason score tumours ≥ 7 compared with PSA ≥ 3 ng/mL. Here, KLK3 is linked to neoplasm.